Detalhe da pesquisa
1.
Flt3L Treatment of Bone Marrow Donors Increases Graft Plasmacytoid Dendritic Cell Content and Improves Allogeneic Transplantation Outcomes.
Biol Blood Marrow Transplant
; 25(6): 1075-1084, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30503387
2.
Peritransplantation Red Blood Cell Transfusion Is Associated with Increased Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 24(5): 973-982, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29307717
3.
New molecule for mobilizing marrow stem cells.
Blood
; 123(3): 310-1, 2014 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-24434996
4.
Successful treatment of severe immune hemolytic anemia after allogeneic stem cell transplantation with bortezomib: report of a case and review of literature.
Transfusion
; 55(2): 259-64, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25156334
5.
Plerixafor alone for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells.
Blood Adv
; 3(6): 875-883, 2019 03 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30890544
6.
A novel mutation causing type 1 Gaucher disease found in a Japanese patient with gastric cancer: A case report.
Medicine (Baltimore)
; 97(27): e11361, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29979419
7.
Central nervous system involvement of acute promyelocytic leukemia, three case reports.
Clin Case Rep
; 5(5): 645-653, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28469869
8.
Chemokine and lymph node homing receptor expression on pDC vary by graft source.
Oncoimmunology
; 3(10): e958957, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25941585